Joseph Tucker, PhD, CEO of Enveric Biosciences, Naples, FL, discusses the potential of psychedelics to treat mental health issues such as depression and anxiety in cancer patients. These mental health issues can lead to poorer outcomes for patients, as well as greatly decreasing quality of life, so creating effective treatments is vital. Dr Tucker discusses how Enveric Biosciences is working on the early pre-clinical development of a novel variant of psilocybin.